0 items USD 0.00Search
Your search for "global markets direct neuroblastoma pipeline review h1 2017" gave back 819845 results.
The global Chemotherapy Drugs for Neuroblastoma market size is projected to grow from US$ 120.3 million in 2022 to US$ 166.8 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Immunotherapy Drugs for Neuroblastoma market size is projected to grow from US$ 44 million in 2022 to US$ 61 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market is projected to...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Neuroblastoma Treatment market size was valued at US$ 434.3 million in 2023. With growing demand in downstream market, the Neuroblastoma...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Immunotherapy for Neuroblastoma market size is projected to grow from US$ 44 million in 2022 to US$ 61 million in 2029; it is expected to...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Chemotherapy for Neuroblastoma market size is projected to grow from US$ 120.3 million in 2022 to US$ 166.8 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Chemotherapy for Neuroblastoma market size was valued at USD 126.6 million in 2022 and is forecast to a readjusted size of USD 171.1...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Immunotherapy for Neuroblastoma market size was valued at USD 46 million in 2022 and is forecast to a readjusted size of USD 63 million by...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Chemotherapy (chemo) is the use of anti-cancer drugs, which are usually given into a vein. The drugs enter the bloodstream and travel throughout the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Chemotherapy for Neuroblastoma market size is expected to reach $ 171.1 million by 2029, rising at a market growth of 4.4% CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Immunotherapy for Neuroblastoma market size is expected to reach $ 63 million by 2029, rising at a market growth of 4.4% CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
